169 related articles for article (PubMed ID: 36061038)
1. Patient-centered mobile tuberculosis treatment support tools (TB-TSTs) to improve treatment adherence: A pilot randomized controlled trial exploring feasibility, acceptability and refinement needs.
Iribarren SJ; Milligan H; Chirico C; Goodwin K; Schnall R; Telles H; Iannizzotto A; Sanjurjo M; Lutz BR; Pike K; Rubinstein F; Rhodehamel M; Leon D; Keyes J; Demiris G
Lancet Reg Health Am; 2022 Sep; 13():. PubMed ID: 36061038
[TBL] [Abstract][Full Text] [Related]
2. Mobile Tuberculosis Treatment Support Tools to Increase Treatment Success in Patients with Tuberculosis in Argentina: Protocol for a Randomized Controlled Trial.
Iribarren S; Milligan H; Goodwin K; Aguilar Vidrio OA; Chirico C; Telles H; Morelli D; Lutz B; Sprecher J; Rubinstein F
JMIR Res Protoc; 2021 Jun; 10(6):e28094. PubMed ID: 34152281
[TBL] [Abstract][Full Text] [Related]
3. Insights from participant engagement with the tuberculosis treatment support tools intervention: Thematic analysis of interactive messages to guide refinement to better meet end user needs.
Milligan H; Iribarren SJ; Chirico C; Telles H; Schnall R
Int J Med Inform; 2021 May; 149():104421. PubMed ID: 33706032
[TBL] [Abstract][Full Text] [Related]
4. Acceptability of a Digital Adherence Tool Among Patients With Tuberculosis and Tuberculosis Care Providers in Kilimanjaro Region, Tanzania: Mixed Methods Study.
Mtenga AE; Maro RA; Dillip A; Msoka P; Emmanuel N; Ngowi K; Sumari-de Boer M
Online J Public Health Inform; 2024 Jun; 16():e51662. PubMed ID: 38922643
[TBL] [Abstract][Full Text] [Related]
5. Electronic pillbox-enabled self-administered therapy versus standard directly observed therapy for tuberculosis medication adherence and treatment outcomes in Ethiopia (SELFTB): protocol for a multicenter randomized controlled trial.
Manyazewal T; Woldeamanuel Y; Holland DP; Fekadu A; Blumberg HM; Marconi VC
Trials; 2020 May; 21(1):383. PubMed ID: 32370774
[TBL] [Abstract][Full Text] [Related]
6. An intervention to improve the quality of life in children of parents with serious mental illness: the Young SMILES feasibility RCT.
Abel KM; Bee P; Gega L; Gellatly J; Kolade A; Hunter D; Callender C; Carter LA; Meacock R; Bower P; Stanley N; Calam R; Wolpert M; Stewart P; Emsley R; Holt K; Linklater H; Douglas S; Stokes-Crossley B; Green J
Health Technol Assess; 2020 Nov; 24(59):1-136. PubMed ID: 33196410
[TBL] [Abstract][Full Text] [Related]
7. Converting and expanding a mobile support intervention: Focus group and field-testing findings from individuals in active tuberculosis treatment.
Iribarren SJ; Rodriguez Y; Lin L; Chirico C; Discacciati V; Schnall R; Demiris G
Int J Med Inform; 2020 Apr; 136():104057. PubMed ID: 31981744
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of a comprehensive package based on electronic medication monitors at improving treatment outcomes among tuberculosis patients in Tibet: a multicentre randomised controlled trial.
Wei X; Hicks JP; Zhang Z; Haldane V; Pasang P; Li L; Yin T; Zhang B; Li Y; Pan Q; Liu X; Walley J; Hu J
Lancet; 2024 Mar; 403(10430):913-923. PubMed ID: 38309280
[TBL] [Abstract][Full Text] [Related]
9. Carer administration of as-needed subcutaneous medication for breakthrough symptoms in people dying at home: the CARiAD feasibility RCT.
Poolman M; Roberts J; Wright S; Hendry A; Goulden N; Holmes EA; Byrne A; Perkins P; Hoare Z; Nelson A; Hiscock J; Hughes D; O'Connor J; Foster B; Reymond L; Healy S; Lewis P; Wee B; Johnstone R; Roberts R; Parkinson A; Roberts S; Wilkinson C
Health Technol Assess; 2020 May; 24(25):1-150. PubMed ID: 32484432
[TBL] [Abstract][Full Text] [Related]
10. Using a Mobile Health Intervention (DOT Selfie) With Transfer of Social Bundle Incentives to Increase Treatment Adherence in Tuberculosis Patients in Uganda: Protocol for a Randomized Controlled Trial.
Sekandi JN; Onuoha NA; Buregyeya E; Zalwango S; Kaggwa PE; Nakkonde D; Kakaire R; Atuyambe L; Whalen CC; Dobbin KK
JMIR Res Protoc; 2021 Jan; 10(1):e18029. PubMed ID: 32990629
[TBL] [Abstract][Full Text] [Related]
11. Impact of a mobile phone-based interactive voice response software on tuberculosis treatment outcomes in Uganda (CFL-TB): a protocol for a randomized controlled trial.
Byonanebye DM; Mackline H; Sekaggya-Wiltshire C; Kiragga AN; Lamorde M; Oseku E; King R; Parkes-Ratanshi R
Trials; 2021 Jun; 22(1):391. PubMed ID: 34120649
[TBL] [Abstract][Full Text] [Related]
12. TextTB: A Mixed Method Pilot Study Evaluating Acceptance, Feasibility, and Exploring Initial Efficacy of a Text Messaging Intervention to Support TB Treatment Adherence.
Iribarren S; Beck S; Pearce PF; Chirico C; Etchevarria M; Cardinale D; Rubinstein F
Tuberc Res Treat; 2013; 2013():349394. PubMed ID: 24455238
[TBL] [Abstract][Full Text] [Related]
13. Feasibility and Clinical Relevance of a Mobile Intervention Using TrackPAD to Support Supervised Exercise Therapy in Patients With Peripheral Arterial Disease: Study Protocol for a Randomized Controlled Pilot Trial.
Paldán K; Simanovski J; Ullrich G; Steinmetz M; Rammos C; Jánosi RA; Moebus S; Rassaf T; Lortz J
JMIR Res Protoc; 2019 Jun; 8(6):e13651. PubMed ID: 31244477
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of a digital medication event reminder and monitor device for patients with tuberculosis (SELFTB): a multicenter randomized controlled trial.
Manyazewal T; Woldeamanuel Y; Holland DP; Fekadu A; Marconi VC
BMC Med; 2022 Sep; 20(1):310. PubMed ID: 36167528
[TBL] [Abstract][Full Text] [Related]
15. Acceptability, Usefulness, and Ease of Use of an Enhanced Video Directly Observed Treatment System for Supporting Patients With Tuberculosis in Kampala, Uganda: Explanatory Qualitative Study.
Sekandi JN; McDonald A; Nakkonde D; Zalwango S; Kasiita V; Kaggwa P; Kakaire R; Atuyambe L; Buregyeya E
JMIR Form Res; 2023 Nov; 7():e46203. PubMed ID: 37948121
[TBL] [Abstract][Full Text] [Related]
16. Mobile Health Technologies May Be Acceptable Tools for Providing Social Support to Tuberculosis Patients in Rural Uganda: A Parallel Mixed-Method Study.
Musiimenta A; Tumuhimbise W; Atukunda EC; Mugaba AT; Muzoora C; Armstrong-Hough M; Bangsberg D; Davis JL; Haberer JE
Tuberc Res Treat; 2020; 2020():7401045. PubMed ID: 31969998
[TBL] [Abstract][Full Text] [Related]
17. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
18. Feasibility and acceptability pilot of video-based direct observed treatment (vDOT) for supporting antitubercular treatment in South India: a cohort study.
Rodrigues R; Varghese SS; Mahrous M; Ananthaneni Kumar A; Ahmed MN; D'Souza G
BMJ Open; 2023 May; 13(5):e065878. PubMed ID: 37247959
[TBL] [Abstract][Full Text] [Related]
19. A Smartphone App to Improve Medication Adherence in Patients With Type 2 Diabetes in Asia: Feasibility Randomized Controlled Trial.
Huang Z; Tan E; Lum E; Sloot P; Boehm BO; Car J
JMIR Mhealth Uhealth; 2019 Sep; 7(9):e14914. PubMed ID: 31516127
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of implementation and effectiveness of digital adherence technology with differentiated care to support tuberculosis treatment adherence and improve treatment outcomes in Ethiopia: a study protocol for a cluster randomised trial.
Tadesse AW; Mohammed Z; Foster N; Quaife M; McQuaid CF; Levy J; van Kalmthout K; van Rest J; Jerene D; Abdurhman T; Yazew H; Umeta DG; Assefa D; Weldemichael GT; Bedru A; Letta T; Fielding KL
BMC Infect Dis; 2021 Nov; 21(1):1149. PubMed ID: 34758737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
